CAMPOCHIARO, CORRADO
 Distribuzione geografica
Continente #
EU - Europa 79
NA - Nord America 62
AS - Asia 33
Totale 174
Nazione #
US - Stati Uniti d'America 62
IT - Italia 52
CN - Cina 18
SE - Svezia 11
KR - Corea 8
NO - Norvegia 6
IN - India 3
DE - Germania 2
ES - Italia 2
FI - Finlandia 2
FR - Francia 2
HK - Hong Kong 2
IE - Irlanda 1
RU - Federazione Russa 1
SG - Singapore 1
UZ - Uzbekistan 1
Totale 174
Città #
Shanghai 18
Milan 17
New York 16
Ashburn 10
Naples 8
Seongnam-si 8
Vaprio d'Adda 8
Oslo 6
Bergamo 3
Osimo 3
Ancona 2
Angers 2
Barcelona 2
Hyde Park 2
Hyderabad 2
Marana 2
West Jordan 2
Balasore 1
Capaccio 1
Dallas 1
Dublin 1
Frankfurt am Main 1
Helsinki 1
Lappeenranta 1
Lawrence 1
Los Angeles 1
Martina Franca 1
Princeton 1
Santa Clara 1
Tashkent 1
Totale 124
Nome #
Liquid biopsy of cerebrospinal fluid enabling the detection and therapeutic targeting of the BRAFV600E mutation in a patient with overlapping Erdheim-Chester/Rosai-Dorfman disease 28
Efficacy and safety of rituximab biosimilar (CT-P10) in IgG4-related disease: an observational prospective open-label cohort study 21
Does the impact of COVID-19 on patients with systemic sclerosis change over time? 19
Cardiac magnetic resonance findings in acute and post-acute COVID-19 patients with suspected myocarditis 18
Efficacy and safety of apremilast for Behçet's syndrome: a real-life single-centre Italian experience 16
Anakinra for the Treatment of Antisynthetase Syndrome: A Monocentric Case Series and a Systematic Literature Review 14
Myelomonocytic cells in giant cell arteritis activate trained immunity programs sustaining inflammation and cytokine production 13
Myocarditis in anti-synthetase syndrome: clinical features and diagnostic modalities 12
High-dose anakinra in addition to standard of care including corticosteroids in patients with severe COVID-19 treated with non-invasive ventilation 12
Inflammatory rheumatic diseases with onset after SARS-CoV-2 infection or COVID-19 vaccination: a report of 267 cases from the COVID-19 and ASD group 10
Adherence to the Mediterranean Diet in Italian Patients With Systemic Sclerosis: An Epidemiologic Survey 9
Clinical Applications of FDG-PET Scan in Arrhythmic Myocarditis 9
Successful use of ixekizumab for glucocorticoid-free remission maintenance in giant cell arteritis 7
Clinical profiling and outcomes of viral myocarditis manifesting with ventricular arrhythmias 6
Multimodal Detection and Targeting of Biopsy-Proven Myocardial Inflammation in Genetic Cardiomyopathies: A Pilot Report 6
Open questions on the management of targeted therapies for the treatment of systemic sclerosis-interstitial lung disease: results of a EUSTAR survey based on a systemic literature review 6
Giant cell arteritis: Update on clinical manifestations, diagnosis, and management 6
Cardiovascular involvement in Erdheim-Chester diseases is associated with myocardial fibrosis and atrial dysfunction 6
Cardiac involvement, a threatening very early manifestation of systemic sclerosis: evidence from VEDOSS patients 5
Sex influence on outcomes of patients with systemic sclerosis-associated interstitial lung disease: a EUSTAR database analysis 4
Corrigendum to “Intravenous immunoglobulins reduce skin thickness in systemic sclerosis: evidence from Systematic Literature Review and from real life experience” [Autoimmunity Reviews, Volume 20, Issue 12, December 2021, 102981](S1568997221002615)(10.1016/j.autrev.2021.102981) 4
Systemic sclerosis Progression INvestiGation (SPRING) Italian registry: demographic and clinico-serological features of scleroderma spectrum 4
Impact of COVID-19 and vaccination campaign on 1,755 systemic sclerosis patients during first three years of pandemic. Possible risks for individuals with impaired immunoreactivity to vaccine, ongoing immunomodulating treatments, and disease-related lung involvement during the next pandemic phase 4
Systemic sclerosis sine scleroderma: clinical and serological features and relationship with other cutaneous subsets in a large series of patients from the national registry 'SPRING' of the Italian Society for Rheumatology 3
Drug development and novel therapeutics to ensure a personalized approach in the treatment of systemic sclerosis 3
Canakinumab as first-line biological therapy in Still’s disease and differences between the systemic and the chronic-articular courses: Real-life experience from the international AIDA registry 1
Effectiveness of a two-year tapered course of tocilizumab in patients with giant cell arteritis: A single-centre prospective study 1
Case report: Successful use of mepolizumab for immune checkpoint inhibitors–induced hypereosinophilic syndrome in two patients with solid malignancies 1
Totale 248
Categoria #
all - tutte 2.357
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.357


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202 1 0 0 0 0 0 0 0 0 0 1 0
2022/202356 3 2 1 0 0 7 26 10 2 0 4 1
2023/2024190 2 6 9 23 22 32 36 30 3 18 9 0
Totale 248